MedTrace Logo

Testing the Cognitive Facilitation Effect by Dietary Supplementation of MelaGene+ Drink

NCT05988593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2023-08-14

No results posted yet for this study

Summary

To assess the efficacy of MelaGene+ on cognitive performance

Conditions

  • Cognitive Change

Interventions

DIETARY_SUPPLEMENT

placebo

consume one bottle (30 mL) per day

DIETARY_SUPPLEMENT

MelaGene+

consume one bottle (30 mL) per day

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Jing-Ling Li · China Medical University, China

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2022-11-30
Completion
2023-05-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05988593 on ClinicalTrials.gov